prognostic tools

Finding BioMarkers to Drug Sensitivity, The Next Step – ASCO Annual Meeting at ASCO GU

Now that we have new treatments available to fight advanced, metastatic prostate cancer we need ways to decide on the best treatments given that many of the treatments occupy the same disease space. This is especially important with the soaring costs of many treatments as well as the need to not waste time by giving [...]

By Malecare|2017-10-19T10:48:09-04:00June 17th, 2014|Advanced Prostate Cancer, biomarkers, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Clinical Trials, Drugs & Treatments, enzalutamide, prognostic tools, Uncategorized, Understanding APC, Xtandi|0 Comments

Using Circulating Tumor Cells as a Prognostic Tool – Better than PSA

Better prediction tools to predict treatment outcome in men with metastatic castration-resistant prostate cancer (mCRPC) should significantly improve treatment outcomes. Without good predictive measures we often don't know when is the optimum time to stop a therapy and move to another. This means that we might maturely stop an effective treatment losing the effectiveness of [...]

By Malecare|2020-02-04T11:50:07-05:00December 14th, 2013|Advanced Prostate Cancer, CTCs, prognostic tools, Research, Start A Cure, Uncategorized, Understanding APC|0 Comments

Previous 34